ADVFN - Advanced Financial Network.
HOME» LSE » G » GSK Share Price » GSK Share News

Glaxosmithkline Share News

 Glaxosmithkline Share Price
GSK Share Price
 Glaxosmithkline Share Chart
GSK Share Chart
 Glaxosmithkline Share News
GSK Share News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Share Trades
GSK Share Trades
 Glaxosmithkline Share Message Board
GSK Share Message Board

GlaxoSmithKline to close Crawley factory in Sussex, 493 jobs to go

LONDON (Thomson Financial) - GlaxoSmithKline PLC. has announced hundreds of people will lose their jobs when it closes its factory in Sussex in 2011, the BBC reported citing a company spokesman. Some 493 people are expected to be affected when the multinational drugs company's Crawley site closes. The company blamed the closure on "declining volumes, regulatory delays and patent expiries". A spokesman said production at the site would continue until the products had been moved to alternative facilities. The spokesperson said: "GSK sincerely regrets the potential impact of this proposal in terms of job losses and will do all it can to help staff through this difficult period. "Implementation of this proposal will be subject to consultation with trade union and staff representatives at the Crawley site. This process will begin immediately." The factory currently produces medicines to treat Parkinson's disease, heart disease, HIV/AIDS, bacterial skin infections, depression, and hypertension. slm COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.

Share News for Glaxosmithkline (GSK)
06/05/201523:01:31ADR Shares End Mixed; Anheuser-Busch InBev Rises
06/05/201517:54:27EUROPE MARKETS: FTSE 100, Pound Rise As Services Data Come In...
06/05/201514:20:33GlaxoSmithKline PLC Director/PDMR Shareholding
06/05/201513:54:20IN THE KNOW: Liberum Blames Glaxo's Shareholder Return Cut On...
06/05/201513:50:06GSK Cuts Return to Holders From Novartis Asset Swap
06/05/201513:06:51UPDATE: Glaxo Slashes Return To Shareholders, Sets Out Growth...
06/05/201512:58:20Genmab 1Q Sales of Arzerra Leukaemia Drug at GBP11.1 Million
06/05/201512:32:22Glaxo Slashes Return To Shareholders, Sets Out Guidance Through...
06/05/201512:00:20GlaxoSmithKline PLC 1st Quarter Results
06/05/201509:53:50Glaxo's ViiV Begins Phase III Programme For Dolutegravir/Rilpivirine
06/05/201509:51:00ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine...
05/05/201511:01:37GSK, Fondazione, Ospedale Make EU Submission for Gene Therapy...
05/05/201510:20:15Glaxo, Telethon, San Raffaele Submit Gene Therapy EU Application
04/05/201523:47:04GlaxoSmithKline plc 1Q 2015 -- Forecast
01/05/201507:07:14GlaxoSmithKline Says US FDA Approves Breo Ellipta For Asthma...
01/05/201507:00:20GlaxoSmithKline PLC Total Voting Rights
01/05/201507:00:12GlaxoSmithKline PLC FDA approves BREO ELLIPTA for adults with...
30/04/201521:36:00FDA approves BREO® ELLIPTA® for the treatment of adults with a...
30/04/201516:53:39GlaxoSmithKline PLC Director/PDMR Shareholding
29/04/201515:25:46GlaxoSmithKline PLC Director/PDMR Shareholding

Glaxosmithkline Plc and other London Stock Exchange share prices are delayed by at least 20 minutes.
All other share price data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations